Understanding how the interferon system fights viral infections
Novel antiviral mechanisms of the interferon system
This study is looking at how our body fights off viruses like the flu and coronaviruses, and it's trying to find a special protein called TDRD7 that might help stop these viruses from spreading, which could lead to better treatments for viral infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11048814 on NIH RePORTER |
What this research studies
This research investigates the interferon system, which is the body's first line of defense against various viral infections, including coronaviruses and influenza. By using advanced genetic screening techniques, the study aims to identify specific proteins that can inhibit viral replication and enhance the antiviral response. The researchers focus on a novel protein called TDRD7, which has been shown to block a critical pathway that viruses use to replicate. This work could lead to new antiviral therapies that are more effective and have fewer side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk of severe respiratory viral infections, such as those with compromised immune systems or underlying health conditions.
Not a fit: Patients who are not at risk for viral infections or those who have already been effectively treated with existing antiviral therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral treatments that improve patient outcomes for those infected with respiratory viruses.
How similar studies have performed: Other research has shown promise in identifying antiviral mechanisms through similar approaches, suggesting that this line of inquiry could yield significant advancements.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Chattopadhyay, Saurabh — University of Kentucky
- Study coordinator: Chattopadhyay, Saurabh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.